12:00 PM EST - Inflazyme Pharmaceuticals Ltd. : on Friday posted financial results for the fourth quarter, reporting a net loss of $3.93 million or $0.03 per share compared to a loss of $9.43 million or $0.08 per share in the corresponding quarter in the previous year. The results for the latest quarter were calculated on 131.18 million shares compared to 113.53 million shares in the year ago quarter. Quarterly revenues remained flat at $9.58 million, while loss from operations narrowed to $15.75 million from $18.89 million in the year ago quarter. Inflazyme Pharmaceuticals Ltd.
shares T.IZP are trading unchanged at $0.04.
